Dermatology Edition: Top Headlines for Week of December 18, 2023
In this edition, an advocacy group petitions the FDA for stronger safety warnings for Botox, melanoma regression is associated with improved prognosis and more. Read the full coverage here:
Advocacy group petitions FDA for stronger safety warnings for Botox, related drugs
Melanoma regression associated with improved prognosis
Phase 4 results show Vtama cream efficacious in head, neck plaque psoriasis
Isotretinoin not associated with increased risk for suicide, psychiatric conditions
Tape strips may identify hidradenitis suppurativa in lesional, nonlesional skin
References:
Navrazhina K, et al. J Am Acad Dermatol. 2023;doi:10.1016/j.jaad.2023.11.048.
Press Release
Press Release
Tan NKW, et al. JAMA Dermatol. 2023;doi:10.1001/jamadermatol.2023.4579.
Wagner NB, et al. J Am Acad Dermatol. 2023;doi:10.1016/j.jaad.2023.11.040.
Create your
podcast in
minutes
It is Free